Article ID Journal Published Year Pages File Type
3317775 Pancreatology 2013 7 Pages PDF
Abstract
In patients with PEI due to CP, treatment with pancreatin for one year was associated with significant improvements in fat absorption, nitrogen absorption, and nutritional parameters, improvements in clinical symptoms, and a favorable safety and tolerability profile.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Gastroenterology
Preview
A 51-week, open-label clinical trial in India to assess the efficacy and safety of pancreatin 40000 enteric-coated minimicrospheres in patients with pancreatic exocrine insufficiency due to chronic pancreatitis
Authors
, , , , , , , ,